Analysis of the adverse events of Aristada:A real-world study based on FAERS database

被引：2
|
作者：
Ou, Mengmeng [1 ]
Zhou, Qin [1 ]
Zhu, Haohao [1 ]
Du, Zhiqiang [1 ]
Shen, Yuan [1 ]
Luan, Peipei [1 ]
Jiang, Ying [1 ]
机构：
[1] Jiangnan Univ, Wuxi Cent Rehabil Hosp, Mental Hlth Ctr, Wuxi 214151, Jiangsu, Peoples R China
来源：
ASIAN JOURNAL OF PSYCHIATRY | 2024年 / 94卷
基金：
中国国家自然科学基金;
关键词：
Aristada; FDA adverse event reporting system; Real -world data analysis; Adverse events; Adverse drug reactions;
D O I：
10.1016/j.ajp.2024.103968
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for denosumab
    He, Yue
    Zhang, Rong
    Shen, Huarui
    Liu, Yingqi
    FRONTIERS IN PHARMACOLOGY, 2024, 15
  • [42] A real-world disproportionality analysis of FDA Adverse Event Reporting System (FAERS) events for baricitinib
    Peng, Ling
    Xiao, Kui
    Ottaviani, Silvia
    Stebbing, Justin
    Wang, Ying-Jie
    EXPERT OPINION ON DRUG SAFETY, 2020, 19 (11) : 1505 - 1511
  • [43] A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for avatrombopag
    Zhong Xue
    Maohua Chen
    Mingzuo Wang
    Fan Zhang
    Zhaoshuo Chen
    Scientific Reports, 14 (1)
  • [44] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Guo, Menglin
    Shu, Yamin
    Chen, Guosong
    Li, Juan
    Li, Feie
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [45] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yanchao Yin
    Yamin Shu
    Junru Zhu
    Feie Li
    Juan Li
    Scientific Reports, 12
  • [46] Gabapentinoids-Related Delirium Adverse Events: A Real-World Study from 2004 to 2022 Based on FAERS
    Nie, Zhongbiao
    Liang, Cuilv
    Li, Zhihong
    Han, Xinqiang
    Zhang, Ran
    JOURNAL OF PAIN RESEARCH, 2024, 17 : 2551 - 2559
  • [47] A real-world disproportionality analysis of FDA adverse event reporting system (FAERS) events for alpelisib
    Lin, Yu
    Zheng, Xinlei
    Chen, Yan
    Nian, Qichun
    Lin, Li
    Chen, Maohua
    HELIYON, 2024, 10 (06)
  • [48] A real-world pharmacovigilance study of FDA Adverse Event Reporting System (FAERS) events for osimertinib
    Yin, Yanchao
    Shu, Yamin
    Zhu, Junru
    Li, Feie
    Li, Juan
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [49] A real-world pharmacovigilance study of FDA adverse event reporting system (FAERS) events for niraparib
    Menglin Guo
    Yamin Shu
    Guosong Chen
    Juan Li
    Feie Li
    Scientific Reports, 12
  • [50] Adverse events associated with teriparatide: a real-world disproportionality analysis of the FDA adverse event reporting system (FAERS)
    Dai, Zhicheng
    Zhang, Jiafeng
    Tao, Zhengbo
    Gao, Rui
    Zhao, Qinghua
    EXPERT OPINION ON DRUG SAFETY, 2024,
12345